ERS International Congress, Milan 2017

---

COPD: from screening to risk factors of lung cancer

Thematic Poster
Chairs: M. Brusse-Keizer (Enschede, Netherlands), A. Langhammer (Levanger, Norway), J. Quint (Wimbledon, United Kingdom), L. Hedman (Luleå, Sweden)

Late Breaking Abstract - Association between blood eosinophils and exacerbation risk in COPD primary care S. Landis (Uxbridge, United Kingdom)
Late Breaking Abstract - Validation of a tool for the assessment of disease awareness (DA) in COPD F. Braido (Genova, Ge, Italy)
Late Breaking Abstract - The socio-economic cost of asthma, COPD and chronic bronchitis in Europe. L. Portas (Bolzano, Italy)
Validation of the PUMA score for detecting COPD in a primary care population at the Hospital Maciel, Montevideo C. Rodriguez Flores (Montevideo, Uruguay)
Costs and health-related quality of life in COPD patients with a-1-antitrypsin deficiency: results of the COSYCONET cohort M. Wacker (Neuherberg, Germany)
Greater progression of COPD in low income ever-smokers K. Lowe (Golden, United States of America)
Predicting admission, a descriptive analysis of acute exacerbation chronic obstructive pulmonary disease (AECOPD) in the emergency department: a retrospective cohort study T. Pletting (Leiden, Netherlands)
Prediction models for the development of COPD: a systematic review G. Bowatte (Reservoir, Australia)
Hand grip strength is associated with fatigue in COPD V. Johansson Strandkvist (Boden, Sweden)
HDL serum levels are significantly lower in patients with COPD than in never-smokers D. Jungck (Berlin, Germany)
Who participates in a bronchoscopy study, and why? E. Martinsen (BJOA, Norway)
Trends in prevalence of COPD in Greater Glasgow and Clyde: relationships with age, sex and socioeconomic status M. Milligan (Glasgow, United Kingdom)
Development a self-scored COPD screening questionnaire in a general Japanese population T. Samukawa (Kagoshima, Japan)
Population Screening for COPD: A comparison of COPD Patient Screener and CAPTURE A. Dilektasli (Bursa, Turkey)
COPD incidence in subjects with risk factors, chronic respiratory symptoms and normal spirometry: The PLATINO study> E. Sanchez Angarita (Caracas, Distrito Capital, Venezuela)
COPD severity using GOLD 2017 in real life: The French Palomb Cohort C. Raherison-Semjen (Pessac, France)
Risk factors for lung cancer in COPD G. Husebø (Fana, Norway)
The prevalence of Chronic Obstructive Pulmonary Disease (COPD) in Sri Lanka:outcome of the BOLD study K. Gunasekera (Colombo, Sri Lanka)
Elevated blood eosinophils on admission for a severe exacerbation of COPD is not a predictor for survival E. Citgez (Wierden, Netherlands)
The prevalence and clinical characteristics of asthma–COPD overlap syndrome (ACOS) in patients with COPD I. Cekerevac (Kragujevac, Republic of Serbia)